Child Survival Working Group
Accessed: 30.10.2019
Review
Drake AL et al. Journal of the International AIDS Society 2019, 22:e25271 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25271/full | https://doi.org/10.1002/jia2.25271
Journal of Infection and Public Health 12 (2019) 213–223
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
World TB Day 24 March 2012
Accessed: 21.10.2019
Zhou et al. Int J Ment Health Syst (2019) 13:10 https://doi.org/10.1186/s13033-019-0263-1
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
A super-fast-track Framework for ending AIDS among children, adolescents and young women by 2020
Accessed: 02.11.2019
Child Survival Working Group
Accessed: 02.11.2019
All In #EndAdolescentAIDS
Global Webinar: Novel Approaches for Addressing Age of Consent as a Barrier to Adolescents' Care Utilization and Engagement
Accessed: 26.10.2019
UNICEF’s Global HIV Response 2018 – 2021
Accessed: 02.11.2019
Best Practices Guidelines
Accessed: 06.11.2019